1 | 12:30-12:33 |
主席致辞 |
|
||||
2 | 12:33-12:35 |
主席致辞 |
|
1 | 12:35-12:45 |
夜尿症诊疗专家经验分享 |
|
||||
2 | 12:45-12:55 |
夜尿症诊疗专家经验分享 |
|
1 | 12:55-13:20 |
问题1:夜尿症作为老年常见疾病,如何使夜尿症疾病诊疗意识在临床和患者中得到进一步普及? 问题2:对于夜尿症或者伴随夜尿症症状的患者,临床如何考虑药物治疗的介入,在患者管理的过程中需要关注哪些问题? 问题3:您认为夜尿症领域药物治疗发展和探索的方向有哪些? |
|
1 | 13:30-13:35 |
Two-Year Outcomes of The Prostatic Urethral Lift in Japan: A Multicenter, Prospective Cohort Study |
|
||||
2 | 13:35-13:40 |
Expression Characteristics and Regulation of Yes-Associated Protein 1 in Mechanosensitive Signaling Pathways involved in Oab |
|
||||
3 | 13:40-13:45 |
Analysis of Clinical Presentation and Videourodynamic Parameter in Female Patients with Dysfunctional Voiding |
|
||||
4 | 13:45-13:50 |
Fully End-To-End Automated Bladder Segmentation and Risk Assessment Based on Bladder Morphology Features for Predicting Upper Urinary Tract Dysfunction |
|
||||
5 | 13:50-13:55 |
LonLong-Term Outcomes of Substitution Urethroplasty for Male Urethral Strictures: A 10-Year Follow-Up and Beyondg-Term Outcomes of Substitution Urethroplasty for Male Urethral Strictures: A 10-Year Follow-Up and Beyond |
|
||||
6 | 13:55-14:00 |
Initial Experience of Pneumovesical Vesicovaginal Fistula Repair Using the Da Vinci SP Robotic System |
|
||||
7 | 14:00-14:05 |
Techniques and Surgical Outcomes of Laparoscopic Repair of Vesicovaginal Fistula |
|
||||
8 | 14:05-14:10 |
Urinary Function and Quality of Life Following Management of Prostate Cancer in Community Dwelling Men: The Concord Health and Ageing in Men (Champ) Project |
|
||||
9 | 14:10-14:15 |
The Experience of Artificial Graft Bladder Augmentation for the Treatment of Interstitial Cystitis |
|
||||
10 | 14:15-14:20 |
Optimization of Sacral Neuromodulation Therapy: Clinical Outcomes and Patient Suitability Exploration of Variable Frequency Mode |
|
||||
11 | 14:20-14:25 |
Functional Ultrasound Imaging of the Pelvic Floor Pre and Post Radical Prostatectomy: Correlation with Long Term Continence Outcomes |
|
||||
12 | 14:25-14:30 |
No-Mesh Treatment for Female Stress Urinary Incontinence |
|
||||
13 | 14:30-14:35 |
Clinical Features, Risk Factors and Sequelae of Detrusor Underactivity: A Study of Possible Cause and Effect |
|
||||
14 | 14:35-14:40 |
Initial experience with robot-assisted extraperitoneal transvesical ureteral reimplantation using Da Vinci SP at a single institution |
|
1 | 14:40-14:45 |
Effects of Curcumin on Pro-Inflammatory Cytokine Suppression in a Novel Inflammation-Induced Urothelium-on-a-Chip Model |
|
||||
2 | 14:45-14:50 |
Which Lower Urinary Tract Dysfunction Factors Were Largely Responsible for Urinary Related Quality of Life Deterioration after Robot-Assisted Radical Prostatectomy? |
|
||||
3 | 14:50-14:55 |
Efficacy and Long-Term Follow-Up of Modified T-Plasty for Bladder Neck Contracture After Prostatectomy via laprocscopic |
|
||||
4 | 14:55-15:00 |
Longitudinal Urodynamic Changes and UTI Risk Factors in Neurogenic Bladder Patients Using Clean Intermittent Catheterization |
|
||||
5 | 15:00-15:05 |
Robotic Sacrocolpopexy with Mesh: Functional and Qol Outcomes with Up To 10 Years Follow-Up |
|
||||
6 | 15:05-15:10 |
Modified Bladder Neck Incision for the Treatment of Women with Underactive Bladder and Chronic Urinary Retention: A One-Year Efficacy Summary |
|
||||
7 | 15:10-15:15 |
Bladder Function and Recurrence Outcomes Following TUC and DMSO Therapy in Hunner-Type Interstitial Cystitis |
|
||||
8 | 15:15-15:20 |
Matrix Stiffness Promotes Proliferation and Fibrosis of Prostatic Fibroblasts through Cytoskeletal Remodeling and Yap1 Activation |
|
||||
9 | 15:20-15:25 |
Urodynamic investigation for Predicting Successful Trial without Catheter in Male Patients with Acute Urinary Retention: A Prospective Study |
|
||||
10 | 15:25-15:30 |
Mid-term outcomes of water vapor thermal therapy (WVTT) for benign prostatic hyperplasia (BPH) in high-risk patients: a retrospective analysis |
|
||||
11 | 15:30-15:35 |
Characteristics of Patients with Recurrent Cystitis and Immunostimulant Use: An Analysis Using Nationwide Claims Data in Korea |
|
||||
12 | 15:35-15:40 |
Prospective Evaluation of Bladder Outlet Obstruction After Radiotherapy and Hormonal Therapy for High-risk Localized and Locally Advanced Prostate Cancer Using Pressure-Flow Studies |
|
||||
13 | 15:40-15:45 |
Research and Development of Implantable Bladder Capacity Monitoring System |
|
||||
14 | 15:45-15:50 |
Can patient satisfaction after intravesical botulinum toxin injection be predicted by preoperative uroflowmetry |
|
||||
15 | 15:50-15:55 |
Revisiting the Role of Platelet-Rich Plasma in SUI: A Systematic Review of Therapeutic Outcomes |
|
||||
16 | 15:55-16:00 |
Clinical Characteristics and Prognosis Analysis of 24 Cases Initially Diagnosed as Interstitial Cystitis But Pathologically Confirmed as Bladder Tumors |
|
1 | 16:00-16:05 |
Voiding dysfunction after Radical Prostatectomy |
|
||||
2 | 16:05-16:10 |
Exploratory Study on The Optimal Exercise Training Model for The Treatment of Overactive Bladder |
|
||||
3 | 16:10-16:15 |
Melatonin pretreated urine derived stem cells-extracellular vesicles regulate clock gene expression and improve nocturia in restrained stress mice |
|
||||
4 | 16:15-16:20 |
Vibegron for overactive bladder in patients 80 years or over (HOKUTO) 2 study |
|
||||
5 | 16:20-16:25 |
Escitalopram Can Reverse Co-Occurring Depression and Overactive Bladder Induced By Corticosterone in Rats. |
|
||||
6 | 16:25-16:30 |
Bladder outlet obstruction after radiation therapy |
|
||||
7 | 16:30-16:35 |
Ultrasound Education and Experience in Urology Trainees in Australia and New Zealand: Progress Over 23 Years |
|
||||
8 | 16:35-16:40 |
Cytokine Ccl7-Mediated Activation of Mesenchymal Stem Cells To Promote Urinary Continence Via Periurethral Fibroblasts Mechanism |
|
||||
9 | 16:40-16:45 |
The Anastomosis of Urethral Stricture: The Experience From Shanghai Sixth People'S Hospital |
|
||||
10 | 16:45-16:50 |
Study on Risk Factors and Predictive Value of Upper Urinary Tract Damage in Female Voiding Dysfunction Patients |
|
||||
11 | 16:50-16:55 |
The Digital Paradigm: Transforming Post-Prostatectomy Incontinence Care Through Comprehensive Management |
|
||||
12 | 16:55-17:00 |
Effect of Sscral Neuromodulation on ChronicPelvic Pain Syndrome |
|
||||
13 | 17:00-17:05 |
Urodynamics: With a Focus on Appropriate Indications |
|
||||
14 | 17:05-17:10 |
The Practice of B Ultrasound Assisted SNM (Stage I) |
|
1 | 17:10-17:15 |
Urinary Dysfunction in Parkinson’S Disease |
|
||||
2 | 17:15-17:20 |
Research on Real-Time Recognition of Urodynamic Signals Based on Yolov5 Model. |
|
||||
3 | 17:20-17:25 |
The management of refractory OAB |
|
||||
4 | 17:25-17:30 |
Transurethral Treatment |
|
||||
5 | 17:30-17:35 |
Voiding dysfunction and antiaging |
|
||||
6 | 17:35-17:40 |
Analysis of Clinical Characteristics of Voiding Dysfunction in Female Patients with Overactive Bladder |
|
||||
7 | 17:40-17:45 |
Effectiveness of Peripheral Electrical Neurostimulation for the Management of Neurogenic Lower Urinary Tract |
|
||||
8 | 17:45-17:50 |
The causal relationship between BMI and polyuria: A Mendelian Randomization Study |
|
||||
9 | 17:50-17:55 |
Linking "Deqi "Intensity to Clinical Outcomes: A Study of Electroacupuncture and Pelvic Floor Muscle Training for Male Stress Urinary Incontinence |
|
||||
10 | 17:55-18:00 |
The BDNF-TrkB-MAPK pathway interacts with peripheral clock genes to circadian bladder function |
|
||||
11 | 18:00-18:05 |
Electroacupuncture alleviates overactive bladder by modulating Piezo2-mediated sensory neurons activity |
|
||||
12 | 18:05-18:10 |
Exploring the Mechanisms of Nocturia Caused by Obstructive Sleep Apnea Syndrome from a Traditional Chinese Medicine (TCM) Viewpoint |
|
||||
13 | 18:10-18:15 |
Modified Surgical Approach for Obstructive Bulbar Urethral Stricture: Ventrally Modified Mucomucosal Anastomotic Non-Transecting Augmentation (MANTA) Urethroplasty—A Report of 5 Cases |
|
||||
14 | 18:15-18:20 |
Sacral Neuromodulation for the Treatment of Lower Urinary Tract Dysfunction: A Singer-Center Study Assessing Predictors of Test Phase Success and Long-Term Efficacy |
|
||||
15 | 18:20-18:25 |
Repeated intravesical platelet-rich plasma injection alleviates symptoms in interstitial cystitis/bladder pain syndrome patients |
|